This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Cyclacel Pharmaceuticals Inc
CYCC : NASDAQ : Health Care
$3.17 | %
Today's Range: 3.08 - 3.17
Avg. Daily Volume: 86,500
09/19/14 - 3:59 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
CYCC CYCLACEL PHARMACEUTICALS 3.15 74.08 n/m 1.36 162.04
STEM STEMCELLS INC 1.42 97.47 n/m 1.22 17.09
TRGT TARGACEPT INC 2.61 88.20 n/m 0.22 -95.59
CGIX CANCER GENETICS INC 8.57 83.10 n/m 6.50 21.10
BOTA BIOTA PHARMACEUTICALS INC 2.19 76.86 n/m 69.55 204.44
CYTX CYTORI THERAPEUTICS INC 0.94 74.77 n/m 8.90 -39.36
ARQL ARQULE INC 1.17 73.45 n/m 11.39 -56.49
CVM CEL-SCI CORP 0.92 73.30 n/m 0.21 -15.88
SIGA SIGA TECHNOLOGIES INC 1.34 71.70 n/m 4.43 -37.64
OGXI ONCOGENEX PHARMACEUTICALS 3.00 63.41 n/m 35.13 26.50
ADXS ADVAXIS INC 3.24 63.24 n/m 1.00 n/a
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

CYCC Ind Avg S&P 500
n/m 82.53 19.94
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs